NAVB Decision from FDA regarding Priority Review for LS sNDA is expected by 2/17. If granted June PDUFA date expected. Next CHMP meeting week of 2/17. NAVB previously requested additional time to respond to questions from the December meeting so IMO possibly another month or 2 to come up for opinion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.